Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. immune inflammatory
Show results for
Products

Companies

News
Articles

Refine by
Locations

  • USA
  • North America
Brands

  • boston

Boston Immune Inflammatory Equipment & Supplies

6 equipment items found

Boston - Model BOS-572 - Spectrum Serine Beta-Lactamase Inhibitor (BLI)

Boston - Model BOS-572 - Spectrum Serine Beta-Lactamase Inhibitor (BLI)

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS-572 is a broad-spectrum serine beta-lactamase inhibitor (BLI) of the diazabicyclooctane (DBO) ...
CONTACT SUPPLIER

Boston - Model BOS-981 - Small Molecule Furin Inhibitor

Boston - Model BOS-981 - Small Molecule Furin Inhibitor

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS-981 is a first-in-class, small molecule furin inhibitor with therapeutic potential in pulmonary diseases, including cystic fibrosis (CF), vascular diseases, and infectious ...
CONTACT SUPPLIER

Boston - Model BOS161721 - Avizakimab - Human Anti-IL-21 Antibody

Boston - Model BOS161721 - Avizakimab - Human Anti-IL-21 Antibody

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS161721 (avizakimab) is a fully human anti-IL-21 ...
CONTACT SUPPLIER

Boston - Model BOS-228 - Novel Monobactam

Boston - Model BOS-228 - Novel Monobactam

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS-228 is a novel monobactam for infections caused by multidrug-resistant carbapenem-resistant ...
CONTACT SUPPLIER

Boston - Model BOS-421 - Brain Penetrant Inhibitor

Boston - Model BOS-421 - Brain Penetrant Inhibitor

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS-421 is a highly selective, brain penetrant RIPK1 ...
CONTACT SUPPLIER

Boston - Model BOS-475 - Bromodomain and Extra Terminal (BET) Inhibitor

Boston - Model BOS-475 - Bromodomain and Extra Terminal (BET) Inhibitor

Manufactured by:Boston Pharmaceuticals   based inCambridge, MASSACHUSETTS (USA)
BOS-475 potently inhibits multiple clinically validated pathways (IL-12/IL-23-p40, Th17 cytokines and TNF) relevant to psoriasis pathophysiology. BOS-475 demonstrates broad inhibitory activities on other key disease-relevant immune-inflammatory mediators such as MCP-1, IL-6, and CXCL10 & 11. Topical BOS-475 is a potential treatment for psoriasis and other ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT